Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: Potential role for early remodeling in atrial fibrillation

被引:69
|
作者
Gassanov, N
Brandt, MC
Michels, G
Lindner, M
Er, F
Hoppe, UC
机构
[1] Univ Cologne, Dept Internal Med 3, D-50937 Cologne, Germany
[2] Univ Cologne, CMMC, Ctr Mol Med, D-5000 Cologne 41, Germany
关键词
angiotensin; atrial fibrillation; ionic currents; calcium sparks; remodeling;
D O I
10.1016/j.ceca.2005.10.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Atrial angiotensin II (ANG II) levels have been shown to be increased in atrial fibrillation (AF). The purpose of the study was to evaluate a potential role of ANG II in the early remodeling and susceptibility to chronicization of AF. Methods and results: Isolated human atrial myocytes were incubated in ANG II and/or angiotensin type 1 receptor blocker candesartan. ANG II markedly increased the frequency of spontaneous Ca2+ sparks, spark full duration, time to peak Ca2+ fluorescence and decay time measured by confocal imaging. Sarcoplasmic reticulum calcium content estimated by caffeine-evoked calcium release did not differ between ANG II-treated cells and controls. Patch-clamp recordings revealed that ANG II significantly decreased I-to and increased I-Ca,I-L current densities. Candesartan blocked these ANG II-mediated alterations. ANG II exhibited no effect on I-KI, I-Kur and I-f current size. Expression of connexin 40 and connexin 43 was not significantly changed by ANG II as assessed by immunohistochemistry and Western blot analysis. Conclusion: ANG II-induced alterations of calcium handling and electrophysiological changes inhuman atrial cells similar to those previously observed in the onset of AF. Prevention of these alterations by candesartan might constitute a useful pharmacological strategy for the treatment of AF. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:175 / 186
页数:12
相关论文
共 50 条
  • [31] Astragaloside IV inhibits angiotensin II-induced atrial fibrosis and atrial fibrillation by SIRT1/PGC-1α/FNDC5 pathway
    Cong, Xinpeng
    Zhu, Xi
    Zhang, Xiaogang
    Ning, Zhongping
    HELIYON, 2024, 10 (10)
  • [32] Erratum: Expression changes of ionic channels in early phase of cultured rat atrial myocytes induced by rapid pacing
    Wei Cheng
    Qiang Ji
    Hua Liu
    Yunqing Mei
    Xisheng Wang
    Jing Feng
    Wenjun Ding
    Journal of Cardiothoracic Surgery, 10
  • [33] Corilagin inhibits angiotensin II-induced atrial fibrosis and fibrillation in mice through the PI3K-Akt pathway
    Zhang, Xiaogang
    Tian, Bei
    Cong, Xinpeng
    Ning, Zhongping
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2024, 27 (06) : 717 - 724
  • [34] Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 andTGFβ1/Smad2/3 signaling pathways
    Wu, Yingbiao
    Luo, Jun
    Song, Xiang
    Gu, Wei
    Wang, Saihua
    Hao, Shuwen
    Dong, Zhiwu
    Ning, Zhongping
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (06) : 717 - 724
  • [35] EFFECTS OF ANGIOTENSIN II AND TELMISARTAN ON TRANSIENT OUTWARD POTASSIUM AND L-TYPE CALCIUM CURRENTS IN SPRAGUE-DAWLEY RAT ATRIAL MYOCYTES
    Long Yi
    Zhou Yanan
    Fan Jinqi
    HEART, 2011, 97
  • [36] Taurine Prevents Angiotensin II-Induced Human Endocardial Endothelium Morphological Remodeling and the Increase in Cytosolic and Nuclear Calcium and ROS
    Jacques, Danielle
    Bkaily, Ghassan
    NUTRIENTS, 2024, 16 (05)
  • [37] Inhibition of small conductance calcium activated potassium channels in human atrial myocytes by angiotensin II via the AT2 receptor
    Wang Xiaoyu
    Li Miaoling
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C43 - C43
  • [38] Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors
    Touyz, RM
    Sventek, P
    Lariviere, R
    Thibault, G
    Fareh, J
    Reudelhuber, T
    Schiffrin, EL
    HYPERTENSION, 1996, 27 (05) : 1090 - 1096
  • [39] Heat-Shock Protein 72 (HSP72) prevents angiotensin II-induced atrial fibrosis and fibrillation in rat heart
    Saikawa, T.
    Wakisaka, O.
    Takahashi, N.
    Shinohara, T.
    Oie, T.
    Murozono, Y.
    Kohno, H.
    Hara, M.
    EUROPEAN HEART JOURNAL, 2006, 27 : 45 - 46
  • [40] Differential effects of five risk variants for atrial fibrillation at the 4q25 region on L-type calcium current and transient inward currents in human atrial myocytes
    Tarifa, C.
    Herraiz-Martinez, A.
    Llach, A.
    Jimenez-Sabado, V.
    Colino, H.
    Lozano-Velazquez, E.
    Franco, D.
    Rosello, E.
    Rodriguez-Font, E.
    Cinca, J.
    Hove-Madsen, L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 689 - 689